Xi Zhao

Publications

• Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status (Under review) Zhao X, Rødland EA, Sørlie T, Vollan HKM, Russnes HG, Kristensen VN, Lingjærde OC, Børresen-Dale AL. Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status (Under review).
• Breast cancer prognostication and risk prediction in postgenomic era. Zhao, X., Lingjærde, O.C., Børreson Dale, A.L.. The Continuum of Health Risk Assessments. ISBN: 980-953-307-582-7. InTech. 2012
• Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Børresen-Dale AL, Levine AJ, Bargonetti J, Prives C. Cell. 2012; 148 (1-2): 244-58
• Combining gene signatures improves prediction of breast cancer survival. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC. PLoS One. 2011; 6 (3): e17845
• The importance of gene-centring microarray data. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E. Lancet Oncol. 2010; 11 (8): 719-20; author reply 720-1
• Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T. Mol Oncol. 2007; 1 (2): 160-71